Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bitting RL et al. – In acquired hemophilia, increased age, underlying malignancy, and lack of complete remission are risk factors for death. Although the included studies were not randomized, patients treated with combination chemotherapy had the greatest odds of remission and the lowest odds of death.

Related Articles

Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A
Journal of Thrombosis and Haemostasis, 10/28/09    Relevance Score: 82%

Functional independence score in hemophilia: A cross-sectional study assessment of Mexican children
Pediatric Blood & Cancer, 10/08/09    Relevance Score: 82%

Athletic Participation in Severe Hemophilia: Bleeding and Joint Outcomes in Children on Prophylaxis
Pediatrics, 11/02/09    Relevance Score: 80%

Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors
Journal of Thrombosis and Haemostasis, 10/28/09    Relevance Score: 80%

Kinetics of factor VIII:C inhibitors and treatment response in severe hemophilia A patients
International Journal of Laboratory Hematology, 10/28/09    Relevance Score: 80%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address